Bibliography

Found 1068 results

2012

Panos SE, Hinkin CH, Thames AD, Del Re AC, Patel SM, Valdes-Sueiras M, Mathisen G, Donovan S, Singer EJ, Levine AJ. Longitudinal effects of APOE e4 on HIV-Associated Neurocognitive Dysfunction. In: Annual Meeting of the International Neuropsychological Society. Annual Meeting of the International Neuropsychological Society. ; 2012.

Best BM, Letendre SL, Koopmans P, Rossi SS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, J McCutchan A, et al. Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr. 2012 ;59(4):376-81.

Croteau D, Best BM, Letendre S, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JAllen, et al. Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration. AIDS. 2012 ;26(7):890-3.

Holman AG, Gabuzda D. A Machine Learning Approach for Identifying Amino Acid Signatures in the HIV Env Gene Predictive of Dementia. PLoS ONE [Internet]. 2012 ;7(11). Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23166702

Holzinger ER, Hulgan T, Ellis RJ, Samuels DC, Ritchie MD, Haas DW, Kallianpur AR, Bloss CS, Clifford DB, Collier AC, et al. Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol. 2012 ;18(6):511-20.

Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D. Monocyte Activation Markers in Cerebrospinal Fluid Are Associated with Impaired Neurocognitive Testing in Advanced HIV Infection. In: AAN Meeting. AAN Meeting. New Orleans, Louisiana; 2012. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22569268

Arentoft A, Byrd D, Robbins RN, Monzones J, Miranda C, Rosario A, Coulehan K, Fuentes A, Kubo-Germano K, D'Aquila E, et al. Multidimensional effects of acculturation on English-language neuropsychological test performance among HIV+ Caribbean Latinas/os. Journal of Clinical and Experimental Neuropsychology [Internet]. 2012 ;34(8):814-825. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22624844

Gelman B, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, Masliah E, Commins D, Brandt D, Grant I, et al. The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment. PLoS One [Internet]. 2012 ;7(9). Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0046178

Thames AD. Neurobehavioral and Functional Consequences of HIV in African Americans: A multimethod analysis. 2012 .

Liu G, Fiala M, Mizwicki MT, Sayre JW, Magpantay LI, Siani A, Mahanian M, Chattopadhyay M, La Cava A, Wiedau-Pazos M. Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1. Am J Neurodegener Dis [Internet]. 2012 ;1:60-74. Available from: http://www.ncbi.nlm.nih.gov/pubmed?term=Neuronal%20phagocytosis%20by%20inflammatory%20macrophages%20in%20ALS%20spinal%20cord%3A%20inhibition%20of%20inflammation%20by%20resolvin%20D1.

Zhou L, Pupo GM, Gupta P, Liu B, Tran SL, Rahme R, Wang B, Rua R, Rizos H, Carroll A, et al. A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration. BMC Genomics. 2012 ;13:677.

Kamat A, Misra V, Cassol E, Ancuta P, Yan Z, Li C, Morgello S, Gabuzda D. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy. PLoS ONE [Internet]. 2012 ;7(2). Available from: http://www.ncbi.nlm.nih.gov/pubmed/22363505

Gelman B, Lisinicchia JG, Chen T, Johnson K, Jennings K, Freeman DH, Soukup VM. Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmacol [Internet]. 2012 ;8:1-15. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419353/

Robinson-Papp JS, Elliott K, Simpson DM, Morgello S, Bank MHIVB. Problematic Prescription Opioid Use in an HIV-Infected Cohort: The Importance of Universal Toxicology Testing. J Acquir Immune Defic Syndr [Internet]. 2012 . Available from: http://www.ncbi.nlm.nih.gov/pubmed/22820804

Panos SE. Relationship between Apolipoprotein Genotype and Cognition in HIV. 2012 .

McCutchan JA, Marquie-Beck JA, Fitzsimons CA, Letendre SL, Ellis RJ, Heaton RK, Wolfson T, Rosario D, Alexander TJ, Marra C, et al. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012 ;78(7):485-92.

Shapshak P. Single nucleotide polymorphisms (SNPs) for genome wide association studies (GWAS) and molecule of the month Nitric Oxide Synthase, multiple interactive pathways for three similar genes, Nitric Oxide Synthase-1, -2, -3 (NOS-1, -2, -3). Bioinformation. 2012 ;8(11):496-7.

Mamik MK, Ghorpade A. Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase (SHP)2 and p38 Regulate the Expression of Chemokine CXCL8 in human astrocytes. PLoS One [Internet]. 2012 ;7:e45596. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23029125

Robinson-Papp JS. Substance use increases the risk of neuropathy in an HIV-infected cohort. Muscle and Nerve [Internet]. 2012 ;45:471-476. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22431078

Croteau D, Letendre S, Best BM, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, et al. Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrob Agents Chemother. 2012 ;56(4):1985-9.

2011

Panos SE, Levine AJ, Thames AD, Singer EJ, Jarvik L, Hinkin CH. Advancing age & APOE e4 predict HIV-associated neurocognitive decline. 2011 .

Zhou D, Masliah E, Spector SA. Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis. The Journal of Infectious Diseases [Internet]. 2011 ;203:1647-57. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21592995

Cosenza-Nashat MA, Bauman A, Zhao ML, Morgello S, Suh H-S, Lee SC. Cannabinoid Receptor Expression in HIV Encephalitis and HIV-associated Neuropathologic Comorbidities. Neuropathology and Applied Neurobiology [Internet]. 2011 ;37(5):464-483. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21450051

Fields J, Gardner-Mercer J, Borgmann K, Clark I, Ghorpade A. CCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1. Journal of Neurochemistry [Internet]. 2011 ;118(1):93-104. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21281310

Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011 ;25(14):1747-51.

Pages